✦ LIBER ✦

Stroke prevention with the oral direct thrombin inhibitor ximelagatran compared with warfarin in patients with non-valvular atrial fibrillation (SPORTIF III): randomised controlled trial

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Stroke prevention with the oral direct t

📂 Article 📅 2004 🏛 Elsevier Science 🌐 English ⚖ 41 KB

Risks and benefits of combining aspirin

✍ Greg C. Flaker; Michael Gruber; Stuart J. Connolly; Steven Goldman; Sandra Chapa 📂 Article 📅 2006 🏛 Elsevier Science 🌐 English ⚖ 117 KB

Adjusted-dose warfarin versus low-intens

📂 Article 📅 1996 🏛 The Lancet 🌐 English ⚖ 53 KB

Population pharmacokinetic analysis of t

✍ K.-H. LIESENFELD; T. LEHR; C. DANSIRIKUL; P. A. REILLY; S. J. CONNOLLY; M. D. EZ 📂 Article 📅 2011 🏛 John Wiley and Sons 🌐 English ⚖ 402 KB

Percutaneous closure of the left atrial

✍ David R Holmes; Vivek Y Reddy; Zoltan G Turi; Shephal K Doshi; Horst Sievert; Ma 📂 Article 📅 2009 🏛 The Lancet 🌐 English ⚖ 192 KB

Population pharmacokinetic analysis of t

✍ J. P. PATEL; B. GREEN; R. K. PATEL; J. G. DAVIES; R. ARYA 📂 Article 📅 2012 🏛 John Wiley and Sons 🌐 English ⚖ 89 KB